APhA Pain Institute: Naloxone: Understanding Its Role and Expanding Access in Community Pharmacies (pre-registration required)


Drug overdose is the leading cause of unintentional death in the United States, and opioids are the most common cause of fatal overdoses. With the ability to stop an overdose in its tracks, naloxone is a lifesaving medication. Learn about the laws surrounding its use, the available naloxone products, and the logistics of dispensing take-home formulations. 

Pre-registration is required; click here to register.

Pharmacist Learning Objectives

At the completion of this application-based activity, participants will be able to:

  1. Describe validated tools and practice-based methods to assess the risk for opioid-induced respiratory depression.
  2. Identify models for overdose education and naloxone distribution that are applicable to various practice settings.
  3. Describe strategies to overcome some of the barriers to implementing overdose education and naloxone distribution.
  4. Summarize and demonstrate essential patient/caregiver overdose education elements for community and health care settings.
  5. Explain evolving state laws regarding options for pharmacists to prescribe or dispense naloxone under collaborative practice agreements, protocols or standing orders.
Anita Jacobson, PharmD
Clinical Associate Professor
University of Rhode Island
Sarah Melton, PharmD, BCPP, BCACP, FASCP
Professor of Pharmacy Practice
East Tennessee State University Gatton College of Pharmacy
Learning Level: Level 2
Track: APhA Pain Institute
Session Time Slot(s): 
Thursday, March 15
3:15 PM - 4:30 PM
Music City Center - Room 107A-B
ACPE Pharmacist: 0202-0000-18-046-L01-P
CEUs Pharmacist: 0.25
Activity Type: